Status:
COMPLETED
WALANT in Distal Radius Fracture Osteosynthesis
Lead Sponsor:
Hospital Arnau de Vilanova
Collaborating Sponsors:
Institut de Recerca Biomèdica de Lleida
Conditions:
Radius Fracture Distal
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the applicability and potential benefits of Wide Awake Local Anesthesia No Tourniquet (WALANT) or Local Anesthesia No Tourniquet ("LANT) versus locoregional anes...
Eligibility Criteria
Inclusion
- Patients who attended our hospital from December 2020th to December 2021 with DRF requiring surgical treatment who provided written informed consent and did not have any of the following excluding conditions described below
Exclusion
- Unsigned informed consent
- 17 years old or younger
- Associated fractures in which additional osteosynthesis was required: scaphoid fracture, ulnar fracture (ulnar styloid osteosynthesis included), bifocal radius fractures, etc
- Open fractures
- Polytrauma patients
- Requiring more than a standard volar DRF approach and/or other than a volar plate.
- DRF with \>30 days or DRF malunions Contraindications to the use of ischemia
- a. Peripheral vascular disease b. Extensive soft tissue injury c. Peripheral neuropathy d. Severe infection e. Thromboembolic disease in the extremity f. Poor skin conditions g. Arteriovenous fistula h. Sickle cell hemoglobinopathy
- Contraindications for proximal blocking:
- Existence of previous trauma or anatomical distortion of the area that prevents the abduction of the arm
- Active presence of infection at the locoregional anesthesia puncture site
- Previous axillary lymphadenopathy
- Previous history of local anesthetic allergy
- Severe coagulopathy
- Severe pre-existing neurological diseases in the upper extremity
- Contraindications for WALANT anesthetic technique
- Documented hypersensitivity to lidocaine
- Compromised peripheral circulation
- Patients with previous vascular pathology, a history of vasculitis, Buerger's disease, and scleroderma
- Patients with infection of the area surrounding the injection
Key Trial Info
Start Date :
December 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT05421000
Start Date
December 20 2020
End Date
December 31 2021
Last Update
June 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Arnau Vilanova
Lleida, Segria, Spain, 25198